Currently Available Licenses
KelAda Pharmachem is actively seeking licensees to our proprietary manufacturing process for Pregabalin.
The key features of the process are as follows:
• Estimated cost of materials (ton scale) ca. US$27/kg for the (S)-enantiomer
• The related racemic process is also very competitive with an estimated cost of materials (ton scale) of ca. US$22/kg
• Robust and scalable process
• No Temperature extremes required
• All solvents class 2 or 3
To discuss licensing this process, please contact us.
To view the patent application, please click here
Licenses coming soon
We have a pipeline of similarly impactful license opportunities which will be available in the coming months including:
Montelukast (RMC ca. US$250/kg)
Duloxetine (RMC ca. US$55/kg)
Atomoxetine (RMC ca. US$55/kg)
KelAda Pharmachem is actively seeking licensees to our proprietary manufacturing process for Pregabalin.
The key features of the process are as follows:
• Estimated cost of materials (ton scale) ca. US$27/kg for the (S)-enantiomer
• The related racemic process is also very competitive with an estimated cost of materials (ton scale) of ca. US$22/kg
• Robust and scalable process
• No Temperature extremes required
• All solvents class 2 or 3
To discuss licensing this process, please contact us.
To view the patent application, please click here
Licenses coming soon
We have a pipeline of similarly impactful license opportunities which will be available in the coming months including:
Montelukast (RMC ca. US$250/kg)
Duloxetine (RMC ca. US$55/kg)
Atomoxetine (RMC ca. US$55/kg)